Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Restructuring Costs (2017)

Charles River Laboratories International (CRL) posted quarterly Restructuring Costs of $17.7 million for Q4 2017.

Charles River Laboratories International (CRL) Restructuring Costs (2017) Analysis & Trends

Charles River Laboratories International's Restructuring Costs history runs 1 years deep, the most recent figure standing at $17.7 million for Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn

Historic Data

Download Data
DateValue
Dec 30, 2017 18.10 Mn